Review

Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine

Number: 014 December 30, 2025
EN TR

Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine

Abstract

Copper nanoparticles (CuNPs) have emerged as versatile nanomaterials with significant biomedical potential owing to their unique optical, electrical, thermal, and catalytic properties. As an essential trace element, copper plays a pivotal role in various physiological processes, including metabolism, cardiovascular health, and tissue regeneration, making its nanoscale forms particularly relevant for medical applications. This review offers a thorough synthesis of existing research on CuNPs. Encompassing their preparation via chemical, physical, and biologically mediated (green) approaches, alongside detailed characterization techniques essential for correlating size, morphology, and surface chemistry with biological performance. Special emphasis is placed on their multifunctional roles in antimicrobial therapy, targeted drug delivery, cancer treatment, and imaging-guided diagnostics, as well as their integration into theranostic platforms. The toxicological profile of CuNPs, including their cellular interactions, generation of reactive oxygen species (ROS), and potential environmental impact, is critically discussed. Furthermore, the review outlines recent advances and future perspectives, highlighting the importance of precise synthesis control, advanced characterization, and rigorous safety evaluation to facilitate the safe and effective clinical translation of these technologies. This review aims to link synthesis strategies, physicochemical properties, and biomedical functionalities of CuNPs while identifying challenges and research priorities that can accelerate their translation from laboratory to clinical practice.

Keywords

References

  1. [1] L. Chen, J. Min, and F. Wang, “Copper homeostasis and cuproptosis in health and disease,” Signal Transduct. Target. Ther., vol. 7, no. 1, p. 378, 2022.
  2. [2] X. Chen et al., “Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies,” Cell Death Dis., vol. 14, no. 2, p. 105, 2023.
  3. [3] J. Sailer et al., “Deadly excess copper.” Redox Biol., vol. 75, p. 103256, Sep. 2024, doi: 10.1016/j.redox.2024.103256.
  4. [4] M. Rondanelli et al., “Copper as dietary supplement for bone metabolism: a review,” Nutrients, vol. 13, no. 7, p. 2246, 2021.
  5. [5] R. Liu, J. Yao, K. Chen, and W. Peng, “Association between biomarkers of zinc and copper status and heart failure: a meta-analysis.” ESC Hear. Fail., vol. 11, no. 5, pp. 2546–2556, Oct. 2024, doi: 10.1002/ehf2.14837.
  6. [6] J. Naradala, A. Allam, V. R. Tumu, and R. K. Rajaboina, “Antibacterial activity of copper nanoparticles synthesized by Bambusa arundinacea leaves extract,” Biointerface Res. Appl. Chem, vol. 12, pp. 1230–1236, 2021.
  7. [7] G. M. El-Sherbiny, M. E. Shehata, and M. H. Kalaba, “Biogenic copper and copper oxide nanoparticles to combat multidrug-resistant Staphylococcus aureus: Green synthesis, mechanisms, resistance, and future perspectives,” Biotechnol. Reports, vol. 46, p. e00896, 2025, doi: https://doi.org/10.1016/j.btre.2025.e00896.
  8. [8] S. V. Gudkov, D. E. Burmistrov, P. A. Fomina, S. Z. Validov, and V. A. Kozlov, “Antibacterial properties of copper oxide nanoparticles,” Int. J. Mol. Sci., vol. 25, no. 21, p. 11563, 2024.

Details

Primary Language

English

Subjects

Environmental Nanotechnology and Nanometrology, Nanochemistry, Nanomaterials

Journal Section

Review

Publication Date

December 30, 2025

Submission Date

August 11, 2025

Acceptance Date

September 16, 2025

Published in Issue

Year 2025 Number: 014

APA
Elaibi, H., Mutlag, F., Halvacı, E., & Şen, F. (2025). Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine. Journal of Scientific Reports-B, 014, 24-40. https://izlik.org/JA54KH33DH
AMA
1.Elaibi H, Mutlag F, Halvacı E, Şen F. Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine. Journal of Scientific Reports-B. 2025;(014):24-40. https://izlik.org/JA54KH33DH
Chicago
Elaibi, Hussein, Farah Mutlag, Ebru Halvacı, and Fatih Şen. 2025. “Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine”. Journal of Scientific Reports-B, nos. 014: 24-40. https://izlik.org/JA54KH33DH.
EndNote
Elaibi H, Mutlag F, Halvacı E, Şen F (December 1, 2025) Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine. Journal of Scientific Reports-B 014 24–40.
IEEE
[1]H. Elaibi, F. Mutlag, E. Halvacı, and F. Şen, “Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine”, Journal of Scientific Reports-B, no. 014, pp. 24–40, Dec. 2025, [Online]. Available: https://izlik.org/JA54KH33DH
ISNAD
Elaibi, Hussein - Mutlag, Farah - Halvacı, Ebru - Şen, Fatih. “Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine”. Journal of Scientific Reports-B. 014 (December 1, 2025): 24-40. https://izlik.org/JA54KH33DH.
JAMA
1.Elaibi H, Mutlag F, Halvacı E, Şen F. Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine. Journal of Scientific Reports-B. 2025;:24–40.
MLA
Elaibi, Hussein, et al. “Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine”. Journal of Scientific Reports-B, no. 014, Dec. 2025, pp. 24-40, https://izlik.org/JA54KH33DH.
Vancouver
1.Hussein Elaibi, Farah Mutlag, Ebru Halvacı, Fatih Şen. Copper Nanoparticles: Synthesis, Characterization, and Their Applications in Medicine. Journal of Scientific Reports-B [Internet]. 2025 Dec. 1;(014):24-40. Available from: https://izlik.org/JA54KH33DH